Event Title: 2nd AI Pharma Innovation: Drug Discovery 2019 Summit

ID: 16212


Title/Topic
2nd AI Pharma Innovation: Drug Discovery 2019 Summit
Provider
Hanson Wade
Venue
Marines' Memorial Club and Hotel, 609 Sutter Street, 94102
City/Town
San Francisco
Country
United States
Event Type
Conference
Date of event
27 Feb 2019
Duration
Start on Wednesday February 27, 2019 at 8:00 am ends Thursday February 28, 2019 at 5:00 pm
Who should attend?
Fees (link)
Conference Only Standard: USD 2899.0, Register and Pay before November 16, 2018: USD 2199.0, Register and Pay before December 14, 2018: USD 2399.0, Register and Pay before January 25, 2019: USD 2599.0
CPD/CME Points
Summary of event
Optimize the Real World Application and Practical Implementation of AI and Machine Learning to Improve and Speed Up the Drug Discovery Process!
Programme/Speakers
How to register
URLs: Booking: https://go.evvnt.com/298943-0?pid=5366 Tickets: https://go.evvnt.com/298943-2?pid=5366 Website: https://go.evvnt.com/298943-3?pid=5366 Contact: Hanson Wade Info, info@hansonwade.com, + 1 415 735 3289
Additional Information
The 2nd AI PI: Drug Discovery 2019 Summit is back in San Francisco this February. This summit brings together those leading the surge in utilizing AI to streamline drug discovery. These key decision makers from pharma, biotech drug developers and technology companies will meet to discuss the real world applications of AI technologies in Drug Discovery, and how this is augmenting traditional RandD to lead to quicker, cheaper and more-effective drug discovery. This year’s meeting will build upon this success of 2018 by delivering more practical case studies where AI has been applied to drug discovery and insights into the practical application of AI in your drug discovery pipeline. Join our community and takeaway valuable insights and technical expertise to apply AI to precise and focussed areas within drug discovery to gain the maximum rewards from the continued application of AI in drug discovery. The AI pharma summit was fantastic. The information I got was beyond exceptional. Not only did I get an overview of theories and approaches for utilizing AI in different drug discovery processes but I also got to understand the challenges facing the industry and the possible solutions. The case studies were informative and enlightening. Sammy Cui, Senior Research Associate, Unilever Exceptionally focused meeting joining high level strategic thinking with meaningful technical detail. Excellent slate of attendees and speakers, and in particular an amazing density of productive interstitial and after-hours networking. I’ll be very happy to attend similar meetings in the future. Ari Allyn-Feuer, University of Michigan Medical School
Programme/Speakers (attachment): No attachment